FDA Grants Rare Pediatric Disease Designation To Quoin's QRX003 For PSS

Quoin Pharmaceuticals received FDA Rare Pediatric Disease designation for QRX003, its treatment candidate for Peeling Skin Syndrome. The designation supports development of a therapy for a rare pediatric condition and could enhance the program's regulatory and commercial value, although no clinical efficacy or approval data were reported.